As of Dec 14
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 54.00, with a high estimate of 58.00 and a low estimate of 46.00. The median estimate represents a +0.09% increase from the last price of 53.95.
The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.